Cumba, Carmen G.

HRN: 17 34 49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/06/2022
10/12/2022
IVTT
4.5 G
Q8
Urosepsis,
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: